| ¿µ¹® | sympathetic nervous system | ÇÑ±Û | ±³°¨½Å°æ°è |
|---|---|---|---|
| ¼³¸í | ÀÚÀ²½Å°æ°èÀÇ ÀÏÁ¾À¸·Î ³»Àå±â´ÉÀ» ÁÖ·Î Ç×Áø½ÃÄÑ È°µ¿À» Áõ°¡½ÃŰ´Â ±â´ÉÀ» °¡Áø´Ù. ÀÚÀ²½Å°æ°èÀÇ ´Ù¸¥ °è¿ÀÎ ºÎ±³°¨½Å°æ°è´Â ¹Ý´ë·Î ³»Àå±â´ÉÀ» ¾ïÁ¦½ÃÄÑ ¿¡³ÊÁö¸¦ ºñÃàÇÏ´Â ±â´ÉÀ» °¡Áø´Ù. ÀÚÀ²½Å°æ°èÀÇ ÇØºÎÇÐÀû Ư¼ºÀº ½Å°æÀÌ ÁßÃ߽Űæ°è¿¡¼ ³ª¿Í ¸ñÇ¥Àå±â¿¡ µµ´ÞÇϱâ Àü¿¡ ÇѹøÀÇ ½Ã³À½º(synapse)¸¦ ÀÌ·é´Ù´Â Á¡À̸ç, µû¶ó¼ ÀÚÀ²½Å°æ°è´Â µÎ °³ÀÇ ½Å°æ(½Ã³À½º¸¦ ÀÌ·ç±â ÀüÀÇ ÀýÀü½Å°æ°ú ÀÌ·é ÈÄÀÇ ÀýÈĽŰæ)À¸·Î ±¸¼ºµÈ´Ù. ÀÚÀ²½Å°æ°èÁß ±³°¨½Å°æ°è´Â ÁßÃ߽Űæ°è Áï ô¼ö ºÎ±ÙÀÇ ±³°¨½Å°æÀý(sympathetic ganglion)¿¡¼ ½Ã³À½º°¡ ÀϾ°í, ºÎ±³°¨ ½Å°æ°è´Â ÁßÃ߽Űæ°è¿¡¼ ¸Ö¸® ¶³¾îÁø ¸ñÇ¥ Àå±âºÎ±ÙÀÇ ½Å°æÀý(ganglion)¿¡¼ ½Ã³À½º°¡ ÀϾ´Â Á¡ÀÌ ´Ù¸£´Ù. |
||
| ¿µ¹® | musculoskeletal System | ÇÑ±Û | ±Ù°ñ°Ý°è |
|---|---|---|---|
| ¼³¸í | ±ÙÀ°°ú ÀÌµé ±ÙÀ°ÀÌ ºÙ¾î¼ °°ÀÌ È°µ¿À» ¼öÇàÇÏ´Â °ñ°Ý(»À¸¦ ÅëÅÐ¾î ¸»ÇÔ)À» ÇÔ²² ºÎ¸£´Â ¸». µû¶ó¼ ¿©±âÀÇ ±ÙÀ°Àº ¸ðµÎ °¡·Î¹«´Ì±Ù¿¡ ¼ÓÇϸç, ¼öÀÇÀûÀ¸·Î ¿òÁ÷ÀÏ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | muscular system | ÇÑ±Û | ±ÙÀ°°èÅë |
|---|---|---|---|
| ¼³¸í | ±ÙÀ°¿¡ ÀÇÇØ ÀÌ·ç¾îÁø ÇϳªÀÇ °èÅëÀ» ÀÓÀÇÀûÀ¸·Î ³ª´©¾î ºÎ¸¥ ¸». |
||
| ¿µ¹® | lymphatic system | ÇÑ±Û | ¸²ÇÁ°è |
|---|---|---|---|
| ¼³¸í | ´ë°³ ¸Æ°ü°è¶ó°í Çϸé, Ç÷°ü°è¿Í ¸²ÇÁ°ü°è¸¦ ÇÕÃļ ¸»ÇÑ´Ù. ÀÌÁß¿¡ ¸²ÇÁ¿¡ ÀÇÇØ ÀÌ·ç¾îÁö´Â ÇϳªÀÇ °èÅëÀÌ´Ù. |
||
| GITS | gastrointestinal therapeutic system |
|---|---|
| MDS | Master of Dental Surgery; maternal deprivation syndrome; medical data screening; medical data system... |
| MPS | meconium plug syndrome; medial premotor system; Member of the Pharmaceutical Society; microbial prof... |
| AFP | Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
| endoscopy, gastrointestinal | Visual examination of the gastrointestinal tract by means of a fibreoptic endoscope. It is used to localise, identify, and photograph pathologic alterations, to obtain biopsy material and perform other surgical interventions, and for delivery of medication. (12 Dec 1998) |
|---|---|
| tuberculosis, gastrointestinal | Gastric and/or enteric tuberculosis. This condition is marked by spreading ulcers and diarrhoea. (12 Dec 1998) |
| tuberculosis: gastrointestinal manifestations | <radiology> Ileocaecal area, most common site (80-90%), Stierlin sign, Fleischner sign, thickened ileocaecal valve, fissures, ulcers, sinus tracts, fistulas, perforation, colon, segmental involvement; especially on right side, ulcerating colitis with pseudopolyps, hourglass stricture, wall thickening, gastroduodenal area, simultaneous involvement of pylorus and duodenum, stenotic pylorus with gastric outlet obstruction, narrowed antrum (linitis plastica appearance), ulcers, thickened folds, antral fistula, oesophagus, least common site, ulcers, stricture, mass, sinus tracts (12 Dec 1998) |
| adrenergic blocking agent | A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's. (05 Mar 2000) |
| adrenergic neuronal blocking agent | A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines. (05 Mar 2000) |
| agent | <pharmacology> Any power, principle or substance capable of producing an effect, whether physical, chemical or biological. Origin: L. Agens = acting (18 Nov 1997) |
| agent, antihypertensive | As the name suggests, a drug aimed at reducing high blood pressure (hypertension). (12 Dec 1998) |
| agent, anti-infective | Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. (12 Dec 1998) |
| Agent Orange | An herbicide and defoliant, consisting of (2,4,5-trichlorophenoxy)acetic acid, (2,4-dichlorophenoxy)acetic acid, and dioxin, that was widely used in the Vietnam War; it has been shown to possess residual post-exposure carcinogenic and teratogenic properties in humans. (05 Mar 2000) |
| agent, tocolytic | A medication that can inhibit labour, slow down or halt the contractions of the uterus. Tocolytic agents are widely used today to treat premature labour and permit pregnancy to procede and so let the foetus gain in size and maturity before being born. (12 Dec 1998) |
| alkylating agent | <oncology, pharmacology> A reagent that places an alkyl group, for example propyl in place of a nucleophilic group in a molecule. Alkylating reagents include a number of cytotoxic drugs some of which react fairly specifically with N7 of the purine ring and lead to depurination of DNA, for example the agent ethyl ethanesulphonic acid and thus to mutagenesis. The drugs interaction with DNAand prevents the division of the cells. Examples of drugs include: busulphan, chlorambucil, cyclophosphamide, melphalan. (29 Sep 1997) |
| alpha-adrenergic blocking agent | An agent that competitively blocks alpha-adrenergic receptors; used in the treatment of hypertension. Synonym: alpha-blocker. (05 Mar 2000) |
| antianxiety agent | A functional category of drugs useful in the treatment of anxiety and able to reduce anxiety at doses which do not cause excessive sedation (e.g., diazepam). Synonym: anxiolytic, minor tranquilliser. (05 Mar 2000) |
| antidiabetic agent | A substance that helps a person with diabetes control the level of glucose (sugar) in the blood so that the body works as it should. See: insulin. (09 Oct 1997) |
| antifibrinolytic agent | Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive haemorrhage and in other coagulation disorders. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|